Fanous Hani K, Delgado-Villata Silvia, Kovacs Reka, Shalaby-Rana Eglal, Sami-Zakahri Iman
Division of Pulmonary & Sleep Medicine, Children's National Health System, Washington, DC 20010, USA.
Pediatric Pulmonary & Allergy Division, University of Florida, Gainesville, FL 32608, USA.
Children (Basel). 2018 Jul 3;5(7):91. doi: 10.3390/children5070091.
Cystic fibrosis (CF) is the most common fatal genetic diseases in the United States in Caucasians. More than 2000 genetic mutations have been described and CF is now known to affect other races. The incidence of CF in individuals of Hispanic descent is estimated to be 1:9200. An uncommon mutation, 1811+1643G>T, was recently reported. We report four patients with the 1811+1643G>T mutation (homozygous or heterozygous) and describe their clinical features and compare them to the remainder of our Hispanic cohort group. The homozygous patients had a more severe phenotype compared to the Hispanic cohort in the following areas: their pancreatic status, forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC), chronic (PA) colonization, pulmonary exacerbations requiring oral and intravenous antibiotics, and hospitalization rate. These preliminary findings suggest that future studies investigating the clinical trajectory with a larger cohort of patients homozygous for the 1811+1643G>T mutation are needed.
囊性纤维化(CF)是美国白种人中最常见的致命性遗传疾病。已发现超过2000种基因突变,现在已知CF会影响其他种族。据估计,西班牙裔血统个体中CF的发病率为1:9200。最近报道了一种罕见的突变,即1811 + 1643G>T。我们报告了4例携带1811 + 1643G>T突变(纯合或杂合)的患者,描述了他们的临床特征,并将其与我们西班牙裔队列组的其他患者进行比较。与西班牙裔队列相比,纯合患者在以下方面具有更严重的表型:胰腺状况、1秒用力呼气量(FEV1)和用力肺活量(FVC)、慢性肺部(PA)定植、需要口服和静脉用抗生素治疗的肺部加重情况以及住院率。这些初步发现表明,未来需要对更大规模的1811 + 1643G>T突变纯合患者队列进行临床轨迹研究。